Brevan Howard Capital Management LP Ginkgo Bioworks Holdings, Inc. Transaction History

Brevan Howard Capital Management LP

  • $14.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.28 - $1.16 $60,691 - $251,434
216,754 Added 64.54%
552,576 $182,000
Q1 2024

May 15, 2024
BUY
$1.06 - $1.67 $8,732 - $13,757
8,238 Added 2.51%
335,822 $389,000
Q4 2023

Feb 14, 2024
SELL
$1.26 - $1.79 $467,419 - $664,032
-370,968 Reduced 53.11%
327,584 $553,000
Q1 2023

May 15, 2023
BUY
$1.2 - $2.19 $838,262 - $1.53 Million
698,552 New
698,552 $929,000

Others Institutions Holding DNA

# of Institutions
40
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email